Jean-Philippe Combal, Vivet Therapeutics’ CEO, will be attending the 3rd Annual Gene Therapy for Rare Disorders conference in Boston (March 26-28 2019).
Vivet Therapeutics - innovative gene therapy treatments for orphan diseases
Jean-Philippe Combal, Vivet Therapeutics’ CEO, will be attending the 3rd Annual Gene Therapy for Rare Disorders conference in Boston (March 26-28 2019).